Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Oppenheim

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Neuro-Chirurgie|September 19, 2008
[Childhood cerebral tumors: morbidity and follow-up into adulthood]J Grill, S Puget, E De Carli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinomaS Temam, J Spicer, F Farzaneh, et al.
Medical and Pediatric Oncology|January 22, 1998
Guidelines for a therapeutic alliance between families and staff: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric OncologyG Masera, J J Spinetta, M Jankovic, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Neuro-Chirurgie|September 19, 2008
[Childhood cerebral tumors: morbidity and follow-up into adulthood]J Grill, S Puget, E De Carli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinomaS Temam, J Spicer, F Farzaneh, et al.
Medical and Pediatric Oncology|January 22, 1998
Guidelines for a therapeutic alliance between families and staff: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric OncologyG Masera, J J Spinetta, M Jankovic, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Pageof 10